KIDNEY CANCER
Clinical trials for KIDNEY CANCER explained in plain language.
Never miss a new study
Get alerted when new KIDNEY CANCER trials appear
Sign up with your email to follow new studies for KIDNEY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves zap kidney tumors in first human trial
Disease control CompletedThis study tested a new device that uses focused ultrasound (histotripsy) to break apart solid kidney tumors without making any cuts. Twenty adults with small, non-spreading kidney tumors were treated. The main goals were to see if the device could fully cover the tumor and if th…
Matched conditions: KIDNEY CANCER
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
Can a drug keep kidney cancer away after surgery? trial results in
Disease control CompletedThis phase 3 trial tested whether taking everolimus for a year after kidney cancer surgery could prevent the cancer from coming back. Over 1500 patients with high-risk kidney cancer participated. The study compared everolimus to a placebo to see if it improved recurrence-free sur…
Matched conditions: KIDNEY CANCER
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New hope for kidney cancer patients with brain tumors?
Disease control CompletedThis study tested a drug called sunitinib in 21 people with kidney cancer that had spread to the brain. The goal was to see if the drug could shrink brain tumors. Sunitinib works by blocking enzymes that help cancer cells grow and by cutting off blood flow to tumors. The study wa…
Matched conditions: KIDNEY CANCER
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Two-Drug combo shows promise against metastatic kidney cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs—high-dose interleukin-2 and pembrolizumab—in 27 adults with metastatic kidney cancer. The goal was to see if the combination could shrink tumors. Participants received both drugs in a coordinated schedule. The trial is no…
Matched conditions: KIDNEY CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Simple breath test may reveal who benefits from cancer immunotherapy
Diagnosis CompletedThis study tested whether a simple, non-invasive breath test can predict if cancer patients will benefit from immunotherapy drugs. Researchers analyzed the breath of 190 adults with lung, melanoma, bladder, kidney, or head and neck cancers to see if unique chemical patterns could…
Matched conditions: KIDNEY CANCER
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC